Lv1
14 积分 2021-05-14 加入
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
21小时前
已完结
Prostate cancer
2天前
已完结
PIONEER big data platform for prostate cancer: lessons for advancing future real-world evidence research
2天前
已完结
Targeting and engineering biomarkers for prostate cancer therapy
3天前
已完结
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer
22天前
已完结
Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial
23天前
已完结
De-Escalation Strategies in Human Epidermal Growth Factor Receptor 2 (HER2)–Positive Early Breast Cancer (BC): Final Analysis of the West German Study Group Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early BC HER2- and Hormone Receptor–Positive Phase II Randomized Trial—Efficacy, Safety, and Predictive Markers for 12 Weeks of Neoadjuvant Trastuzumab Emtansine With or Without Endocrine Therapy (ET) Versus Trastuzumab …
1个月前
已完结
Prevalence and Spectrum of AR Ligand-Binding Domain Mutations Detected in Circulating-Tumor DNA Across Disease States in Men With Metastatic Castration-Resistant Prostate Cancer
1个月前
已完结
The key roles of the lysine acetyltransferases KAT6A and KAT6B in physiology and pathology
2个月前
已完结
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
2个月前
已完结
皖公网安备34019202002308
